CoChat

Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia

Open access
· 2019 · New England Journal of Medicine
Cited by 33

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

In the APPROACH trial (Aug. 8 issue), 1 volanesorsen — an antisense oligonucleotide targeting APOC3 messenger RNA — reduced circulating triglycerides in patients with familial chylomicronemia syndrome, but thrombocytopenia developed in 76% of treated patients. This unexpected adverse event raises a key question regarding inhibition of apolipoprotein C-III synthesis as a therapeutic strategy: is thrombocytopenia an on-target effect of reduced apolipoprotein C-III activity or an off-target effect of volanesorsen? therefore inactivating are the an

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc1912350

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 33

Metadata

Venue
New England Journal of Medicine
Published
2019-12-26
Volume
381
Issue
26
Pages
2582-2584
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2997837055
Cited by
33
References
5
FWCI
3.10
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.